IMRIS Inc IMRSQ
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- $0.00
- Day Range
- $0.00–0.00
- 52-Week Range
- $0.00–0.00
- Bid/Ask
- — / —
- Market Cap
- $62.59
- Volume/Avg
- 38,200 / 38,200
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- —
- Dividend Yield (Trailing)
- —
- Dividend Yield (Forward)
- —
- Total Yield
- —
Company Profile
IMRIS Inc designs, manufactures and markets Image-guided therapy systems that improves the effectiveness of therapy delivery. Its main product is the Visius surgical theater. The company provides its products to hospitals that deliver clinical services to patients in the neurosurgical, spinal, cerebrovascular and cardiovascular markets. The firm is focused on bringing enhanced visualization to the point of therapy delivery and is spread across Canada, United States, Europe and the Middle East and Asia-Pacific.
- Sector
- Healthcare
- Industry
- Medical Devices
- Stock Style Box
- Small Value
- Total Number of Employees
- 121
- Website
- http://www.imris.com
Valuation
|
Metric
|
IMRSQ
|
|---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | — |
Price/Sales | — |
Price/Cash Flow | — |
Price/Earnings
No chart available
Financial Strength
|
Metric
|
IMRSQ
|
|---|---|
Quick Ratio | 0.69 |
Current Ratio | 1.10 |
Interest Coverage | −5.59 |
Quick Ratio
IMRSQ
Profitability
|
Metric
|
IMRSQ
|
|---|---|
Return on Assets (Normalized) | −40.50% |
Return on Equity (Normalized) | −131.49% |
Return on Invested Capital (Normalized) | −57.11% |
Return on Assets
IMRSQ
Medical Devices Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|
ABT
| Abbott Laboratories | Mtppjhgg | Rssbq | $185.5 Bil | |
SYK
| Stryker Corp | Sydghvkjn | Vrxt | $128.2 Bil | |
MDT
| Medtronic PLC | Ckfcnzwrd | Zljfqhs | $106.7 Bil | |
BSX
| Boston Scientific Corp | Llrcrpt | Qgtyx | $99.0 Bil | |
DXCM
| DexCom Inc | Kjyhqsgty | Cnj | $53.1 Bil | |
EW
| Edwards Lifesciences Corp | Dwsghljxjv | Djvtccl | $52.8 Bil | |
ZBH
| Zimmer Biomet Holdings Inc | Chdmfswtr | Qsrwv | $24.9 Bil | |
ALGN
| Align Technology Inc | Hqttdvm | Pbggdsz | $23.5 Bil | |
PHG
| Koninklijke Philips NV ADR | Jdxfmhws | Rxpxhl | $18.9 Bil | |
PODD
| Insulet Corp | Dntppsgrtn | Hnmhfn | $11.7 Bil |